GDF2 and telangiectasis: Atypical telangiectasias were evident in both homozygous patients (Q26X and E279X) in our previous report, both of whom lacked detectable plasma BMP9, pBMP10 and serum‐derived HMEC1‐BRE activity (Hodgson et al., 2021).